Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation. [electronic resource]
Producer: 20080313Description: 333-43 p. digitalISSN:- 1742-481X
- Adult
- Aged
- Amputation, Surgical -- statistics & numerical data
- Analysis of Variance
- Diabetes Mellitus, Type 1 -- complications
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Foot -- drug therapy
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Epidermal Growth Factor -- administration & dosage
- Female
- Follow-Up Studies
- Granulation Tissue -- drug effects
- Humans
- Injections, Intralesional
- Male
- Middle Aged
- Probability
- Risk Assessment
- Severity of Illness Index
- Statistics, Nonparametric
- Treatment Outcome
- Wound Healing -- drug effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.